The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
Champness, J.N., Achari, A., Ballantine, S.P., Bryant, P.K., Delves, C.J., Stammers, D.K.(1994) Structure 2: 915-924
- PubMed: 7866743 
- DOI: https://doi.org/10.1016/s0969-2126(94)00093-x
- Primary Citation of Related Structures:  
1DYR - PubMed Abstract: 
The fungal pathogen Pneumocystis carinii causes a pneumonia which is an opportunistic infection of AIDS patients. Current therapy includes the dihydrofolate reductase (DHFR) inhibitor trimethoprim which is selective but only a relatively weak inhibitor of the enzyme for P. carinii. Determination of the three-dimensional structure of the enzyme should form the basis for design of more potent and selective therapeutic agents for treatment of the disease.
Organizational Affiliation: 
Physical Sciences Department, Wellcome Research Laboratories, Beckenham, Kent, UK.